Acrizanib

Acrizanib Uses, Dosage, Side Effects, Food Interaction and all others data.

Acrizanib is under investigation in clinical trial NCT02355028 (LHA510 Proof-of-concept Study as a Maintenance Therapy for Patients With Wet Age-related Macular Degeneration).

Trade Name Acrizanib
Generic Acrizanib
Acrizanib Other Names Acrizanib
Type
Formula C20H18F3N7O2
Weight Average: 445.406
Monoisotopic: 445.147407337
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Acrizanib
Acrizanib

Innovators Monograph

You find simplified version here Acrizanib

*** Taking medicines without doctor's advice can cause long-term problems.
Share